Glucagon-Like Peptide-1 Receptor Agonism Improves Nephrotoxic Serum Nephritis by Inhibiting T-Cell Proliferation.

MLA

Moschovaki Filippidou, Foteini, et al. “Glucagon-Like Peptide-1 Receptor Agonism Improves Nephrotoxic Serum Nephritis by Inhibiting T-Cell Proliferation.” The American Journal of Pathology, vol. 190, no. 2, Feb. 2020, pp. 400–11. EBSCOhost, https://doi.org/10.1016/j.ajpath.2019.10.008.

APA

Moschovaki Filippidou, F., Kirsch, A. H., Thelen, M., Kétszeri, M., Artinger, K., Aringer, I., Schabhüttl, C., Mooslechner, A. A., Frauscher, B., Pollheimer, M., Niedrist, T., Meinitzer, A., Drucker, D. J., Pieber, T. R., Eller, P., Rosenkranz, A. R., Heinemann, A., & Eller, K. (2020). Glucagon-Like Peptide-1 Receptor Agonism Improves Nephrotoxic Serum Nephritis by Inhibiting T-Cell Proliferation. The American Journal of Pathology, 190(2), 400–411. https://doi.org/10.1016/j.ajpath.2019.10.008

Chicago

Moschovaki Filippidou, Foteini, Alexander H Kirsch, Matthias Thelen, Máté Kétszeri, Katharina Artinger, Ida Aringer, Corinna Schabhüttl, et al. 2020. “Glucagon-Like Peptide-1 Receptor Agonism Improves Nephrotoxic Serum Nephritis by Inhibiting T-Cell Proliferation.” The American Journal of Pathology 190 (2): 400–411. doi:10.1016/j.ajpath.2019.10.008.